AliveCor has received an additional FDA 510(k) clearance, this time for an algorithm that allows its smartphone ECG to detect atrial fibrillation -- an abnormal heart rhythm that isn't always ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--Kardium Inc., the developer of the Globe ® Pulsed Field System – an innovative treatment for atrial fibrillation (AF) – has raised US$250 million in a new ...

Mount Sinai researchers developed an AI model to make individualized treatment recommendations for atrial fibrillation (AF) patients—helping clinicians accurately decide whether or not to treat them ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Atrial fibrillation is the most common arrhythmia worldwide, affecting millions of the general population.

We conducted an international, open-label, randomized, blinded-outcome-assessment trial involving 1284 patients who had undergone successful catheter ablation for atrial fibrillation at least 1 year ...

Lone atrial fibrillation is a form of irregular heartbeat that can cause excessively fast beating. It only affects adults under 60 years old and can be asymptomatic or present symptoms, such as a ...

An individually tailored multidimensional risk-based treatment strategy was not associated with improvements in clinical outcomes compared with usual guideline-based care in patients with atrial ...

Device-detected atrial high-rate episodes (AHREs) are atrial arrhythmias detected by implanted cardiac devices. AHREs resemble atrial fibrillation but are rare and brief. Whether the occurrence of ...

After one year, people taking a GLP-1 drug had better outcomes than those taking an SGLT-2 drug. Specifically, they were 36% less likely to die from any cause, 12% less likely to be hospitalized, 22% ...